NCT01134380View on ClinicalTrials.gov

Genotyping Infarct Patients to Adjust and Normalize Thienopyridine Treatment

CompletedOBSERVATIONAL
Enrollment

1,500

Participants

Timeline

Start Date

June 30, 2010

Primary Completion Date

March 31, 2013

Study Completion Date

March 31, 2013

Conditions
Coronary Artery DiseaseAcute Coronary SyndromeGenetic Resistance to ClopidogrelCompliance to Thienopyridine Treatment
Trial Locations (12)

68003

Hôpital Albert Schweitzer, Colmar

69007

Centre Hospitalier Saint Joseph et Saint Luc, Lyon

91300

Hôpital Privé Jacques Cartier, Massy

Unknown

Centre Hospitalier de la Région Annecienne, Annecy

Centre Hospitalier Sud Francilien, Corbeil-Essonnes

Centre Hospitalier d'Haguenau, Haguenau

Hôpital Bon Secours, Metz

Hôpital Arnaud de Villeneuve, Montpellier

Centre Hospitalier Universitaire Caremeau, Nîmes

Groupe Hospitalier Pitié Salpêtrière, Paris

Centre Hospitalier Rene Dubos, Pontoise

CHI de Villeneuve, Villeneuve-Saint-Georges

Sponsors

Lead Sponsor

Biotronik France
All Listed Sponsors
collaborator

European Cardiovascular Research Center

NETWORK

collaborator

Allies in Cardiovascular Trials Initiatives and Organized

OTHER

lead

Biotronik France

INDUSTRY